Search research articles
Contact Us
Filters
Showing results (311-320 of 320) with videos related to
Page
of 32
Sort By:
You have reached the last page of results.
This site can display upto 320 results.
Blood
|
December 8, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Anne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, et al.
Plos One
|
September 15, 2009
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms
Jose I Martin-Subero, Ole Ammerpohl, Marina Bibikova, et al.
Cells
|
December 11, 2019
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, et al.
The Lancet. Haematology
|
April 7, 2024
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.
Blood
|
July 30, 2025
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>-Internal Tandem Duplication Mutation (SORMAIN)
Andreas Burchert, Gesine Bug, Lea V Fritz, et al.
Journal of Hematology & Oncology
|
September 5, 2022
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Desiree Kunadt, Sebastian Stasik, Klaus H Metzeler, et al.
Plos One
|
April 30, 2016
The Ontology for Biomedical Investigations
Anita Bandrowski, Ryan Brinkman, Mathias Brochhausen, et al.
Blood
|
July 15, 2024
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)
Katja Sockel, Annika Neu, Maren Goeckenjan, et al.
Leukemia
|
August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, et al.
Page
of 32
Search research articles
Search
Showing results (311-320 of 320) with videos related to
Sort By:
Page
of 32
You have reached the last page of results.
This site can display upto 320 results.
Blood
|
December 8, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Anne Sophie Platzbecker, Julia Annabell Georgi, Jan Moritz Middeke, et al.
Plos One
|
September 15, 2009
A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms
Jose I Martin-Subero, Ole Ammerpohl, Marina Bibikova, et al.
Cells
|
December 11, 2019
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients
Halvard Bonig, Zyrafete Kuçi, Selim Kuçi, et al.
The Lancet. Haematology
|
April 7, 2024
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.
Blood
|
July 30, 2025
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2020
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>-Internal Tandem Duplication Mutation (SORMAIN)
Andreas Burchert, Gesine Bug, Lea V Fritz, et al.
Journal of Hematology & Oncology
|
September 5, 2022
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
Desiree Kunadt, Sebastian Stasik, Klaus H Metzeler, et al.
Plos One
|
April 30, 2016
The Ontology for Biomedical Investigations
Anita Bandrowski, Ryan Brinkman, Mathias Brochhausen, et al.
Blood
|
July 15, 2024
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study)
Katja Sockel, Annika Neu, Maren Goeckenjan, et al.
Leukemia
|
August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, et al.
Page
of 32